113 related articles for article (PubMed ID: 7715905)
1. Studies on clinicopathological features of lung cancer patients with K-ras/p53 gene alterations: comparison between younger and older groups.
Kashii T; Mizushima Y; Lima CE; Noto H; Sato H; Saito H; Kusajima Y; Kitagawa M; Yamamoto K; Kobayashi M
Oncology; 1995; 52(3):219-25. PubMed ID: 7715905
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
3. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method.
Kashii T; Mizushima Y; Monno S; Nakagawa K; Kobayashi M
J Cancer Res Clin Oncol; 1994; 120(3):143-8. PubMed ID: 8263009
[TBL] [Abstract][Full Text] [Related]
4. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers.
Kersting M; Friedl C; Kraus A; Behn M; Pankow W; Schuermann M
J Clin Oncol; 2000 Sep; 18(18):3221-9. PubMed ID: 10986054
[TBL] [Abstract][Full Text] [Related]
5. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
7. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
8. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
Kurosawa M
Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.
Dergham ST; Dugan MC; Kucway R; Du W; Kamarauskiene DS; Vaitkevicius VK; Crissman JD; Sarkar FH
Int J Pancreatol; 1997 Apr; 21(2):127-43. PubMed ID: 9209954
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
11. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China.
Rashid A; Ueki T; Gao YT; Houlihan PS; Wallace C; Wang BS; Shen MC; Deng J; Hsing AW
Clin Cancer Res; 2002 Oct; 8(10):3156-63. PubMed ID: 12374683
[TBL] [Abstract][Full Text] [Related]
12. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
[TBL] [Abstract][Full Text] [Related]
13. Low frequency of alterations in p53, K-ras, and mdm2 in rat lung neoplasms induced by diesel exhaust or carbon black.
Swafford DS; Nikula KJ; Mitchell CE; Belinsky SA
Carcinogenesis; 1995 May; 16(5):1215-21. PubMed ID: 7539340
[TBL] [Abstract][Full Text] [Related]
14. Sporadic p53 mutations and absence of ras mutations in glioblastomas.
Gömöri E; Dóczi T; Pajor L; Matolcsy A
Acta Neurochir (Wien); 1999; 141(6):593-9. PubMed ID: 10929724
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
16. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the K-ras and p53 genes in rat lung tumors.
Belinsky SA; Swafford DS; Finch GL; Mitchell CE; Kelly G; Hahn FF; Anderson MW; Nikula KJ
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):901-6. PubMed ID: 9255578
[TBL] [Abstract][Full Text] [Related]
18. Clonal origin of multiple lung cancers: K-ras and p53 mutations determined by nonradioisotopic single-strand conformation polymorphism analysis.
Lau DH; Yang B; Hu R; Benfield JR
Diagn Mol Pathol; 1997 Aug; 6(4):179-84. PubMed ID: 9360838
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I disease after curative resection.
Isobe T; Hiyama K; Yoshida Y; Fujiwara Y; Yamakido M
Jpn J Cancer Res; 1994 Dec; 85(12):1240-6. PubMed ID: 7852188
[TBL] [Abstract][Full Text] [Related]
20. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.
Tortola S; Marcuello E; González I; Reyes G; Arribas R; Aiza G; Sancho FJ; Peinado MA; Capella G
J Clin Oncol; 1999 May; 17(5):1375-81. PubMed ID: 10334521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]